Insulin Glargine
These highlights do not include all the information needed to use INSULIN GLARGINE safely and effectively. See full prescribing information for INSULIN GLARGINE. INSULIN GLARGINE injection, for subcutaneous use Initial U.S. Approval: 2000 This product is LANTUS (insulin glargine).
406883ea-7f97-4eff-8d43-0bab004654f1
HUMAN PRESCRIPTION DRUG LABEL
Jan 3, 2024
Winthrop U.S.
DUNS: 824676584
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
insulin glargine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
insulin glargine
Product Details
FDA regulatory identification and product classification information